Review of the First Edition "The goal of this book, as stated by the authors, is to fill the knowledge gap that exists between developed statistical methods and the applications of these methods. Overall, this book achieves the goal successfully and does a nice job. I would highly recommend it ...The example-based approach is easy to follow and makes the book a very helpful desktop reference for many biostatistics methods."-Journal of Statistical Software Clinical Trial Data Analysis Using R and SAS, Second Edition provides a thorough presentation of biostatistical analyses of clinical trial data with step-by-step implementations using R and SAS. The book's practical, detailed approach draws on the authors' 30 years' experience in biostatistical research and clinical development. The authors develop step-by-step analysis code using appropriate R packages and functions and SAS PROCS, which enables readers to gain an understanding of the analysis methods and R and SAS implementation so that they can use these two popular software packages to analyze their own clinical trial data. What's New in the Second Edition Adds SAS programs along with the R programs for clinical trial data analysis. Updates all the statistical analysis with updated R packages. Includes correlated data analysis with multivariate analysis of variance. Applies R and SAS to clinical trial data from hypertension, duodenal ulcer, beta blockers, familial andenomatous polyposis, and breast cancer trials. Covers the biostatistical aspects of various clinical trials, including treatment comparisons, time-to-event endpoints, longitudinal clinical trials, and bioequivalence trials.

Repeated Measures Design with Generalized Linear Mixed Models for Randomized Controlled Trials is the first book focused on the application of generalized linear mixed models and its related models in the statistical design and analysis of repeated measures from randomized controlled trials. The author introduces a new repeated measures design called S:T design combined with mixed models as a practical and useful framework of parallel group RCT design because of easy handling of missing data and sample size reduction. The book emphasizes practical, rather than theoretical, aspects of statistical analyses and the interpretation of results. It includes chapters in which the author describes some old-fashioned analysis designs that have been in the literature and compares the results with those obtained from the corresponding mixed models. The book will be of interest to biostatisticians, researchers, and graduate students in the medical and health sciences who are involved in clinical trials. Author Website:Data sets and programs used in the book are available at http://www.medstat.jp/downloadrepeatedcrc.html

Analyzing Longitudinal Clinical Trial Data: A Practical Guide provides practical and easy to implement approaches for bringing the latest theory on analysis of longitudinal clinical trial data into routine practice.The book, with its example-oriented approach that includes numerous SAS and R code fragments, is an essential resource for statisticians and graduate students specializing in medical research. The authors provide clear descriptions of the relevant statistical theory and illustrate practical considerations for modeling longitudinal data. Topics covered include choice of endpoint and statistical test; modeling means and the correlations between repeated measurements; accounting for covariates; modeling categorical data; model verification; methods for incomplete (missing) data that includes the latest developments in sensitivity analyses, along with approaches for and issues in choosing estimands; and means for preventing missing data. Each chapter stands alone in its coverage of a topic. The concluding chapters provide detailed advice on how to integrate these independent topics into an over-arching study development process and statistical analysis plan.

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

This book aims to clarify the potential association between frailty and cardiovascular disease in older people. Covering the biological as well as the clinical point of view, it allows researchers and clinicians to discover the significance of this topic. The contributions cover the most important aspects in the potential relationship between frailty and cardiovascular disease. In particular, authoritative authors in this field have clarified the definition and the epidemiology of frailty and cardiovascular disease in older people. A large part of the volume is dedicated to the biological mechanisms of frailty and cardiovascular disease, trying to find those in common between these two conditions. Since this book is dedicated to both researchers and clinicians, we have proposed some chapters to the importance of comprehensive geriatric assessment in the evaluation and treatment of cardiovascular diseases and frailty. In this regard, the importance of geriatric evaluation in cardiac surgery for older people is well covered. Finally, the importance of cardiac rehabilitation and physical exercise is summarized, being, actually, the most important treatments for both frailty and cardiovascular disease. Written by many well-known and widely published experts in their respective fields, this book will appeal to a wide readership such as researchers in the field and clinicians, especially suited in geriatric medicine and cardiology who, every day, face frail older patients.

This book traces the growth in U.S. scientific and political interest in the eradication of cholera and describes the medical research and training facilities founded by the United States in Asia between 1947 and 1980.

With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues related to drug development. However, the available literature on this important topic is sporadic, and often not readily accessible to drug developers or regulatory personnel. This book provides a systematic exposition of the interplay between the two disciplines, including emerging themes pertaining to the acceleration of the development of pharmaceutical medicines to serve patients with unmet needs. Features: Regulatory and statistical interactions throughout the drug development continuum The critical role of the statistician in relation to the changing regulatory and healthcare landscapes Statistical issues that commonly arise in the course of drug development and regulatory interactions Trending topics in drug development, with emphasis on current regulatory thinking and the associated challenges and opportunities The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' decades of experience in the pharmaceutical industry and academia, and extensive regulatory experience, comes through in the many examples throughout the book.

Comparing and Contrasting the Impact of the COVID-19 Pandemic in the European Union challenges the use of uncontextualised comparisons of COVID-19 cases and deaths in member states during the period when Europe was the epicentre of the pandemic. This timely study looks behind the headlines and the statistics to demonstrate the value for knowledge exchange and policy learning of comparisons that are founded on an in-depth understanding of key socio-demographic and public health indicators within their policy settings. The book adopts innovative, integrated, multi-disciplinary international perspectives to track and assess a fast-moving topical subject in an accessible format. It offers a template for analysing policy responses to the COVID-19 pandemic and for using evidence-based comparisons to inform and support policy development.

This book offers a lively account of the humanitarian, economic, societal, and planetwide impacts of the pandemics, the COVID-19 pandemic included, which are traced back to as early as the 14th century plague pandemic. Placing the pandemics along with other globally shared resources, such as global warming, AI singularity, and high-risk physics experiments, each of the nine chapters of the book discusses the global health crises from a variety of unique standpoints, including infectious diseases, economics, governance, and public health. Based on the historical records of past pandemics and the rich data from the COVID-19 pandemic, a conceptual framework is presented for the economics of pandemics as a globally shared experience. This book aims to critically examine salient features in the global responses to the COVID-19 pandemic, including global governance, lockdowns, radical movements, and mRNA vaccines. The book will be a valuable resource to students, researchers, and policymakers who are working in the fields of environmental economics, global-scale public goods, and health economics.

As the novel coronavirus (Covid-19) spread around the world, so did theories, stories, and conspiracy beliefs about it. These theories infected communities from the halls of Congress to Facebook groups, spreading quickly in newspapers, on various social media and between friends. They spurred debate about the origins, treatment options and responses to the virus, creating distrust towards public health workers and suspicion of vaccines. This book examines the most popular Covid-19 theories, connecting current conspiracy beliefs to long-standing fears and urban legends. By examining the vehicles and mechanisms of Covid-19 conspiracy, readers can better understand how theories spread and how to respond to misinformation.

Applied Problem-Solving in Healthcare Management is a practical textbook devoted to developing and strengthening problem-solving and decision-making leadership competencies of healthcare administration students and healthcare management professionals. Built upon the University of Minnesota Master of Healthcare Administration Program's Problem-Solving Method, the text describes the "never assume" mindset and the structured method that drive evidence-based, action-oriented problem-solving. The "never assume" mindset requires healthcare leaders to understand themselves and their stakeholders, and to engage in waves of divergent and convergent thinking. This structured method guides the problem solver through the phases of defining, studying, and acting on complex interrelated organizational problems that involve multiple root causes. The book also describes how the Problem-Solving Method is complementary to quality improvement methods and can be used in healthcare organizations along with Lean, Design Thinking, and Human Centered Design. Providing step-by-step instruction including useful tips, tools, activities, and case studies, this effective resource demonstrates the utility of the method for all types of health organization settings including health systems, hospitals, clinics, population health, and long-term care. For students taking health management, capstone, and experiential learning courses, including internship and residency projects, this book allows them to test and apply their problem-solving and decision-making skills to real-world situations. Beyond the classroom, it is an indispensable resource for organizations seeking to enhance the problem-solving skills of their workforce. The authors of the text have nearly 75 years of combined experience in healthcare management, leadership, and professional consulting, and teaching and advising healthcare administration students in classrooms, on student capstone, internship and residency projects, and case competitions. Synthesizing their expertise, this text serves as a guide for those who wish to strengthen their problem-solving abilities to systematically identify, analyze, study, and solve pressing organizational challenges in healthcare settings. Key Features: Describes a mindset and a structured problem-solving method that builds leadership competencies Encourages a step-by-step problem-solving approach to define, study, and act on problems to drive action-oriented solutions Supports experiential learning and coaching for students and professionals early in their careers, applicable especially to healthcare management, capstone, and student consulting courses, internship and residency projects, case competitions, and professional development in organizations Compares the Problem-Solving Method to other complementary methods used in many healthcare organizations, including Lean, Design Thinking, and Human Centered Design Includes access to the fully downloadable eBook as well as ancillary materials such as Instructor's Manual and Sample Syllabi

Environmental epidemiology is the study of the environmental causes of disease in populations and how these risks vary in relation to intensity and duration of exposure and other factors like genetic susceptibility. As such, it is the basic science upon which governmental safety standards and compensation policies for environmental and occupational exposure are based. Profusely illustrated with examples from the epidemiologic literature on ionizing radiation and air ollution, this text provides a systematic treatment of the statistical challenges that arise in environmental health studies and the use of epidemiologic data in formulating public policy, at a level suitable for graduate students and epidemiologic researchers.
After a general overview of study design and statistical methods for epidemiology generally, the book goes on to address the problems that are unique to environmental health studies, special-purpose designs like two-phase case-control studies and countermatching, statistical methods for modeling exposure-time-response relationships, longitudinal and time-series studies, spatial and ecologic methods, exposure measurement error, interactions, and mechanistic models. It also discusses studies aimed at evaluating the public health benefits of interventions to improve the environment, the use of epidemiologic data to establish environmental safety standards and compensation policy, and concludes with emerging problems in reproductive epidemiology, natural and man-made disasters like global warming, and the global burden of environmentally caused disease. No other book provides such a broad perspective on the methodological challenges in this field at a level accessible to both epidemiologists and statisticians.

Evaluating Climate Change Impacts discusses assessing and quantifying climate change and its impacts from a multi-faceted perspective of ecosystem, social, and infrastructure resilience, given through a lens of statistics and data science. It provides a multi-disciplinary view on the implications of climate variability and shows how the new data science paradigm can help us to mitigate climate-induced risk and to enhance climate adaptation strategies. This book consists of chapters solicited from leading topical experts and presents their perspectives on climate change effects in two general areas: natural ecosystems and socio-economic impacts. The chapters unveil topics of atmospheric circulation, climate modeling, and long-term prediction; approach the problems of increasing frequency of extreme events, sea level rise, and forest fires, as well as economic losses, analysis of climate impacts for insurance, agriculture, fisheries, and electric and transport infrastructures. The reader will be exposed to the current research using a variety of methods from physical modeling, statistics, and machine learning, including the global circulation models (GCM) and ocean models, statistical generalized additive models (GAM) and generalized linear models (GLM), state space and graphical models, causality networks, Bayesian ensembles, a variety of index methods and statistical tests, and machine learning methods. The reader will learn about data from various sources, including GCM and ocean model outputs, satellite observations, and data collected by different agencies and research units. Many of the chapters provide references to open source software R and Python code that are available for implementing the methods.

Absolute Risk: Methods and Applications in Clinical Management and Public Health provides theory and examples to demonstrate the importance of absolute risk in counseling patients, devising public health strategies, and clinical management. The book provides sufficient technical detail to allow statisticians, epidemiologists, and clinicians to build, test, and apply models of absolute risk. Features: Provides theoretical basis for modeling absolute risk, including competing risks and cause-specific and cumulative incidence regression Discusses various sampling designs for estimating absolute risk and criteria to evaluate models Provides details on statistical inference for the various sampling designs Discusses criteria for evaluating risk models and comparing risk models, including both general criteria and problem-specific expected losses in well-defined clinical and public health applications Describes many applications encompassing both disease prevention and prognosis, and ranging from counseling individual patients, to clinical decision making, to assessing the impact of risk-based public health strategies Discusses model updating, family-based designs, dynamic projections, and other topics Ruth M. Pfeiffer is a mathematical statistician and Fellow of the American Statistical Association, with interests in risk modeling, dimension reduction, and applications in epidemiology. She developed absolute risk models for breast cancer, colon cancer, melanoma, and second primary thyroid cancer following a childhood cancer diagnosis. Mitchell H. Gail developed the widely used "Gail model" for projecting the absolute risk of invasive breast cancer. He is a medical statistician with interests in statistical methods and applications in epidemiology and molecular medicine. He is a member of the National Academy of Medicine and former President of the American Statistical Association. Both are Senior Investigators in the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health.

This work explains the purpose of statistical methods in medical studies and analyzes the statistical techniques used by clinical investigators, with special emphasis on studies published in "The New England Journal of Medicine". It clarifies fundamental concepts of statistical design and analysis, and facilitates the understanding of research results.

The Millennium Development Goals, adopted at the UN Millennium Summit in 2000, are the world's targets for dramatically reducing extreme poverty in its many dimensions by 2015?income poverty, hunger, disease, exclusion, lack of infrastructure and shelter while promoting gender equality, education, health and environmental sustainability. These bold goals can be met in all parts of the world if nations follow through on their commitments to work together to meet them. Achieving the Millennium Development Goals offers the prospect of a more secure, just, and prosperous world for all. The UN Millennium Project was commissioned by United Nations Secretary-General Kofi Annan to develop a practical plan of action to meet the Millennium Development Goals. As an independent advisory body directed by Professor Jeffrey D. Sachs, the UN Millennium Project submitted its recommendations to the UN Secretary General in January 2005. The core of the UN Millennium Project's work has been carried out by 10 thematic Task Forces comprising more than 250 experts from around the world, including scientists, development practitioners, parliamentarians, policymakers, and representatives from civil society, UN agencies, the World Bank, the IMF, and the private sector. Coming to Grips with Malaria in the New Millennium presents an innovative strategic framework for relieving the burden that malaria imposes on society through the implementation of tried and tested anti-malarial interventions designed to improve health nationally and to promote economic development locally. Recommendations include early diagnosis, treatment with effective anti-malarial medicines, the use of insecticide treated nets, indoor residual spraying, managing the environment, improving housing, extending health education and improving monitoring and evaluation systems.

Epidemic trend analysis, timeline progression, prediction, and recommendation are critical for initiating effective public health control strategies, and AI and data analytics play an important role in epidemiology, diagnostic, and clinical fronts. The focus of this book is data analytics for COVID-19, which includes an overview of COVID-19 in terms of epidemic/pandemic, data processing and knowledge extraction. Data sources, storage and platforms are discussed along with discussions on data models, their performance, different big data techniques, tools and technologies. This book also addresses the challenges in applying analytics to pandemic scenarios, case studies and control strategies. Aimed at Data Analysts, Epidemiologists and associated researchers, this book: discusses challenges of AI model for big data analytics in pandemic scenarios; explains how different big data analytics techniques can be implemented; provides a set of recommendations to minimize infection rate of COVID-19; summarizes various techniques of data processing and knowledge extraction; enables users to understand big data analytics techniques required for prediction purposes.

The Global Burden of Disease Study (GBD) is one of the largest-scale research collaborations in global health, distilling a wide range of health information to provide estimates and projections for more than 350 diseases, injuries, and risk factors in 195 countries. Its results are a critical tool informing researchers, policy-makers, and others working to promote health around the globe. A study like the GBD is, of course, extremely complex from an empirical perspective. But it also raises a large number of complex ethical and philosophical questions that have been explored in a series of collaborations over the past twenty years among epidemiologists, philosophers, economists, and policy scholars. The essays in this volume address issues of current and urgent concern to the GBD and other epidemiological studies, including rival understandings of causation, the aggregation of complex health data, temporal discounting, age-weighting, and the valuation of health states. The volume concludes with a set of chapters discussing how epidemiological data should and should not be used. Better appreciating the philosophical dimensions of a study like the GBD can make possible a more sophisticated interpretation of its results, and it can improve epidemiological studies in the future, so that they are better suited to produce results that can help us to improve global health.

Geographies of Plague Pandemics synthesizes our current understanding of the spatial and temporal dynamics of plague, Yersinia pestis. The environmental, political, economic, and social impacts of the plague from Ancient Greece to the modern day are examined. Chapters explore the identity of plague DNA, its human mortality, and the source of ancient and modern plagues. This book also discusses the role plague has played in shifting power from Mediterranean Europe to north-western Europe during the 500 years that plague has raged across the continent. The book demonstrates how recent colonial structures influenced the spread and mortality of plague while changing colonial histories. In addition, this book provides critical insight into how plague has shaped modern medicine, public health, and disease monitoring, and what role, if any, it might play as a terror weapon. The scope and breadth of Geographies of Plague Pandemics offers geographers, historians, biologists, and public health educators the opportunity to explore the deep connections among disease and human existence.

This completely revised and updated edition of an outstanding text addresses the fundamental knowledge of epidemiological methods and statistics that can be applied to evolving systems, programs, technologies, and policies. This edition presents new chapters on causal thinking, ethics, and web resources, analyzes data on multinational increases in poverty and longevity, details the control of transmissible diseases, and explains quality management, and the evaluation of healthcare system performance.

Recognised as the most influential publication in the field, ARM facilitates deep understanding of the Rasch model and its practical applications. The authors review the crucial properties of the model and demonstrate its use with examples across the human sciences. Readers will be able to understand and critically evaluate Rasch measurement research, perform their own Rasch analyses and interpret their results. The glossary and illustrations support that understanding, and the accessible approach means that it is ideal for readers without a mathematical background. Highlights of the new edition include: More learning tools to strengthen readers' understanding including chapter introductions, boldfaced key terms, chapter summaries, activities and suggested readings. Greater emphasis on the use of R packages; readers can download the R code from the Routledge website. Explores the distinction between numerical values, quantity and units, to understand the measurement and the role of the Rasch logit scale (Chapter 4). A new four-option data set from the IASQ (Instrumental Attitude towards Self-assessment Questionnaire) for the Rating Scale Model (RSM) analysis exemplar (Chapter 6). Clarifies the relationship between Rasch measurement, path analysis and SEM, with a host of new examples of Rasch measurement applied across health sciences, education and psychology (Chapter 10). Intended as a text for graduate courses in measurement, item response theory, (advanced) research methods or quantitative analysis taught in psychology, education, human development, business, and other social and health sciences. Professionals in these areas will also appreciate the book's accessible introduction.

This book covers applications of fractional calculus used for medical and health science. It offers a collection of research articles built into chapters on classical and modern dynamical systems formulated by fractional differential equations describing human diseases and how to control them. The mathematical results included in the book will be helpful to mathematicians and doctors by enabling them to explain real-life problems accurately. The book will also offer case studies of real-life situations with an emphasis on describing the mathematical results and showing how to apply the results to medical and health science, and at the same time highlighting modeling strategies. The book will be useful to graduate level students, educators and researchers interested in mathematics and medical science.

Obesity continues to accelerate resulting in an unprecedented epidemic that shows no significant signs of slowing down any time soon. The World Health Organization reports that in 2016, nearly 2 billion adults were overweight and that worldwide obesity has nearly tripled since 1975. Obesity: Global Impact and Epidemiology is an important tool in proving a link to new knowledge, serving researchers and clinicians. The field of obesity is evolving very quickly and there is an abundance of scientific data that has emerged and is emerging constantly. Researchers and physicians need new updated information about the epidemiology and global impact of obesity that come from authors that have a wide perspective in the field. For health professionals and researchers, there is a need to understand how obesity begins. While a simple question, the answer is very complex.

A fully updated edition of this key text on mixed models, focusing on applications in medical research The application of mixed models is an increasingly popular way of analysing medical data, particularly in the pharmaceutical industry. A mixed model allows the incorporation of both fixed and random variables within a statistical analysis, enabling efficient inferences and more information to be gained from the data. There have been many recent advances in mixed modelling, particularly regarding the software and applications. This third edition of Brown and Prescott's groundbreaking text provides an update on the latest developments, and includes guidance on the use of current SAS techniques across a wide range of applications. Presents an overview of the theory and applications of mixed models in medical research, including the latest developments and new sections on incomplete block designs and the analysis of bilateral data. Easily accessible to practitioners in any area where mixed models are used, including medical statisticians and economists. Includes numerous examples using real data from medical and health research, and epidemiology, illustrated with SAS code and output. Features the new version of SAS, including new graphics for model diagnostics and the procedure PROC MCMC. Supported by a website featuring computer code, data sets, and further material. This third edition will appeal to applied statisticians working in medical research and the pharmaceutical industry, as well as teachers and students of statistics courses in mixed models. The book will also be of great value to a broad range of scientists, particularly those working in the medical and pharmaceutical areas.

Handbook of Survival Analysis presents modern techniques and research problems in lifetime data analysis. This area of statistics deals with time-to-event data that is complicated by censoring and the dynamic nature of events occurring in time. With chapters written by leading researchers in the field, the handbook focuses on advances in survival analysis techniques, covering classical and Bayesian approaches. It gives a complete overview of the current status of survival analysis and should inspire further research in the field. Accessible to a wide range of readers, the book provides: An introduction to various areas in survival analysis for graduate students and novices A reference to modern investigations into survival analysis for more established researchers A text or supplement for a second or advanced course in survival analysis A useful guide to statistical methods for analyzing survival data experiments for practicing statisticians